IndraLab

Statements

USP22 inhibits Carcinogenesis. 1 / 2

| 1

sparser

"Therefore, our results from the mouse xenograft model demonstrate that USP22 silencing inhibits NSCLC tumorigenesis in vivo through regulating the MDMX–p53 pathway."

25547493

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP22 inhibits Carcinogenesis. 1 / 2

INDRA sources:

Databases

Reading